Indication
Erosive reflux esophagitis; long-term management of patients w/ healed esophagitis to prevent relapse; symptomatic treatment of GERD. Healing of gastric ulcers associated w/ NSAIDs therapy. Prevention of gastric &/or duodenal ulcers associated w/ NSAIDs or low dose aspirin therapy in patients at risk. Maintenance of hemostasis & prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding of gastric or duodenal ulcer. Tab: Upper GI symptoms associated w/ NSAID therapy. In combination w/ an appropriate antibacterial therapeutic regimen for the eradication of H. pylori & healing of H. pylori associated duodenal ulcer & prevention of relapse of peptic ulcer in patients w/ H. pylori-associated ulcers. Pathological hypersecretory conditions including Zollinger-Ellison syndrome & idiopathic hypersecretion. Granules: GERD in childn 1-11 yr. Patients having difficulty swallowing dispersed tab. Inj: Alternative to oral therapy when oral route is not appropriate for GERD in patients w/ erosive reflux esophagitis &/or severe symptoms of reflux in childn & adolescents 1-17 yr.
